Overview
Simply Point develops artificial intelligence tools to analyze gut microbiome data from DNA sequencing. Its GUT-DIET-MAP project is developing a system to personalize dietary interventions and assess the risk of diet-related diseases, supporting early diagnosis and prevention.
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 760 days for 2019).
- 2025not filed
- 202408/05/2025
- 202308/05/2025
- 202208/05/2025
- 202114/11/2022
- 202014/11/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
News
Artificial intelligence in microbiome analysis – new tools for preventive medicine
GUT-DIET-MAP – when the microbiome becomes the new language of medicine
Microbiome as a health biomarker – why the future of medicine begins in the gut
Combining science, data, and artificial intelligence
A new era of medicine based on the microbiome
Industry
Offer
- Platform for microbiological data analysis
- Gut microbiome analysis
- Personalised dietary interventions
- Diet-related disease risk assessment
- Health recommendations
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
Authorized Representatives
Manner of representation
Each member of the management board of the company is authorized to represent the company individually.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Alicja Monika Pasikage 31 | 20 | $270.12 | 20% |
Ireneusz Sękage 48 | 60 | $810.37 | 60% |
Beata Mirosława Stroińskaage 45 | 20 | $270.12 | 20% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2026-06-02.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 11, 2026 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ProactaS.A. | $3,747,821.54 | proacta.pl | ||
| NaturalantibodyS.A. | $3,143,039.05 | naturalantibody.com | ||
| Mymenusp. z o.o. | $533,864.81 | mymenu.pl | ||
| Smart Feedsp. z o.o. | $275,966.58 | smartfeed.com.pl | ||
| Think'n Solvesp. z o.o. | $15,821.20 | tnknsolve.pl | ||
| Global Spacesp. z o.o. | $10,241.87 | globalspace.pl | ||
| RD Projektsp. z o.o. | $1,162.99 | new.rdprojekt.pl | ||
| VitabloomP.S.A. | $0.14 | vitabloom.pl | ||
| Zettagenesp. z o.o. | $0.03 | zettagene.com | ||
| Zirosp. z o.o. | $0.03 | ziro.health |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-23 | Address change (Ul. Polanowska 41, 60-454, Poznań → Jutrzenka 2/18, 60-373, Poznań) | |
| 2025-05-09 | Switch to PKD 2025 (10 PKD 2007 codes → 10 PKD 2025 codes) | |
| 2017-04-19 | Address change (Ul. Wałbrzyska 11/253a, 02-739, Warszawa → Ul. Polanowska 41, 60-454, Poznań) | |
| 2017-04-19 | PKD change (Removed: 5 codes; Added: 5 codes) | |
| 2016-06-16 | Entered in the register |
FAQ
Last updated: 2026-10-14